Search all trials

Find therapies in clinical trials near you – page 6

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Plasma cell myeloma

Recruiting

Registered drugNo placebo

Study of Teclistamab and Lenalidomide as Maintenance Treatment for Newly Diagnosed Multiple Myeloma Patients After Stem Cell Transplantation

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Lenalidomide

Contact Research Centre

Myocarditis

Recruiting

Registered drug

Study on the Safety and Effectiveness of Methylprednisolone Sodium Succinate and Sodium Chloride for Patients with Severe Cardiac Inflammation

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Sodium Chloride

Contact Research Centre

Coronary artery disease

Recruiting

Registered drug

Study on Colchicine for Patients with Coronary Artery Disease After Percutaneous Coronary Intervention

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Colchicine

Contact Research Centre

Aortic valve stenosis

Recruiting

Registered drugNo placebo

Study on Personalized Antithrombotic Therapy with Acenocoumarol, Phenprocoumon, and Apixaban for Patients with Aortic Valve Stenosis Post-TAVI

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Acenocoumarol

Contact Research Centre

Triple negative breast cancer

Recruiting

Registered drugNo placebo

Study of Bicalutamide and Abemaciclib for Patients with Advanced Androgen Receptor Positive Triple-Negative Breast Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drugNo placebo

Study Comparing Telisotuzumab Vedotin and Docetaxel for Adults with Previously Treated Non-Squamous Non-Small Cell Lung Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Docetaxel

Contact Research Centre

Crohn's disease

Recruiting

Registered drugNo placebo

Study on Preventing Crohn's Disease Recurrence After Surgery Using Risankizumab and Drug Combination in Adults at Risk

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Adalimumab

Contact Research Centre

Study Comparing Clindamycin to Rifampicin and Drug Combination for Patients with Prosthetic Joint Infection

Recruiting

Registered drugNo placebo

Study Comparing Clindamycin to Rifampicin and Drug Combination for Patients with Prosthetic Joint Infection

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Clindamycin

Contact Research Centre

Prostate cancer

Recruiting

Registered drugNo placebo

Study on the Effect of Metastasis-Directed Therapy with Lutetium (177Lu) Zadavotide Guraxetan in Patients with Advanced Prostate Cancer and Up to 5 Progressive Lesions

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Abiraterone Acetate

Contact Research Centre

Thrombosis prophylaxis

Recruiting

Registered drugNo placebo

Study on TAK-330 for Reversing Anticoagulation in Patients on Factor Xa Inhibitors Needing Urgent Surgery

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Protein C

Contact Research Centre

Triple negative breast cancer

Recruiting

Registered drugNo placebo

Study of Sacituzumab Govitecan and Pembrolizumab for Patients with Triple Negative Breast Cancer with Residual Disease After Surgery and Therapy

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Non-small cell lung cancer

Not yet recruiting

Registered drugNo placebo

Study of N-803, tislelizumab and docetaxel combination versus docetaxel alone for patients with advanced or metastatic non-small cell lung cancer resistant to immune checkpoint inhibitors

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Find therapies in clinical trials near you – page 6

177 trials match your criteria

Plasma cell myeloma

Study of Teclistamab and Lenalidomide as Maintenance Treatment for Newly Diagnosed Multiple Myeloma Patients After Stem Cell Transplantation

Myocarditis

Study on the Safety and Effectiveness of Methylprednisolone Sodium Succinate and Sodium Chloride for Patients with Severe Cardiac Inflammation

Coronary artery disease

Study on Colchicine for Patients with Coronary Artery Disease After Percutaneous Coronary Intervention

Aortic valve stenosis

Study on Personalized Antithrombotic Therapy with Acenocoumarol, Phenprocoumon, and Apixaban for Patients with Aortic Valve Stenosis Post-TAVI

Triple negative breast cancer

Study of Bicalutamide and Abemaciclib for Patients with Advanced Androgen Receptor Positive Triple-Negative Breast Cancer

Non-small cell lung cancer

Study Comparing Telisotuzumab Vedotin and Docetaxel for Adults with Previously Treated Non-Squamous Non-Small Cell Lung Cancer

Crohn's disease

Study on Preventing Crohn's Disease Recurrence After Surgery Using Risankizumab and Drug Combination in Adults at Risk

Study Comparing Clindamycin to Rifampicin and Drug Combination for Patients with Prosthetic Joint Infection

Study Comparing Clindamycin to Rifampicin and Drug Combination for Patients with Prosthetic Joint Infection

Prostate cancer

Study on the Effect of Metastasis-Directed Therapy with Lutetium (177Lu) Zadavotide Guraxetan in Patients with Advanced Prostate Cancer and Up to 5 Progressive Lesions

Thrombosis prophylaxis

Study on TAK-330 for Reversing Anticoagulation in Patients on Factor Xa Inhibitors Needing Urgent Surgery

Triple negative breast cancer

Study of Sacituzumab Govitecan and Pembrolizumab for Patients with Triple Negative Breast Cancer with Residual Disease After Surgery and Therapy

Non-small cell lung cancer

Study of N-803, tislelizumab and docetaxel combination versus docetaxel alone for patients with advanced or metastatic non-small cell lung cancer resistant to immune checkpoint inhibitors

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.